STAT

How a kidney stone taught me that medicine has changed me

To me, a kidney stone wasn't really a big deal. But to my husband, it was a family crisis, and it taught me how medicine has changed me.

My husband, Peter, texted me one afternoon: His father was violently ill and had been rushed to the hospital. The doctors thought he might have a kidney stone, a painful, but fairly common, ailment that often resolves itself.

I didn’t think much of it —  I talked to my father-in-law, we laughed about drinking more water, and, as I was at work, I moved on to my next patient.

What I didn’t know right away was how concerned my husband was — the image of his father in pain led to several worried phone calls throughout the day.

That night, after dinner, he

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks